Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 1/20 | 0.47 |
| ▸ | F2 | P00734 | 4/20 | 0.45 |
| ▸ | CTSL | P07711 | 3/20 | 0.44 |
| ▸ | CTSS | P25774 | 3/20 | 0.44 |
| ▸ | CTSK | P43235 | 3/20 | 0.44 |
| ▸ | CTSH | P09668 | 1/20 | 0.44 |
| ▸ | CALCR | P30988 | 4/20 | 0.41 |
| ▸ | NMBR | P28336 | 2/20 | 0.41 |
| ▸ | GRPR | P30550 | 2/20 | 0.41 |
| ▸ | CTSD | P07339 | 2/20 | 0.41 |
| ▸ | CTSE | P14091 | 2/20 | 0.41 |
| ▸ | F2R | P25116 | 1/20 | 0.41 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.41 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30827585 | 0.94 | MC4R (0.46) | MC4RF2CTSLCTSSCTSK | |
| SCHEMBL30165153 | 0.90 | MC4R (0.47) | MC4RF2CALCRCTSDCTSE | |
| SCHEMBL30272450 | 0.89 | F2 (0.46) | MC4RF2CALCRCTSDCTSE | |
| SCHEMBL30258236 | 0.88 | F2 (0.45) | MC4RF2CALCRF2R | |
| SCHEMBL30205301 | 0.85 | F2 (0.49) | MC4RF2CTSLCTSSCTSK | |
| SCHEMBL29590547 | 0.85 | OPRK1 (0.46) | MC4RCTSDF2R | |
| SCHEMBL29630560 | 0.85 | OPRK1 (0.46) | MC4RCTSDF2R | |
| SCHEMBL11308638 | 0.85 | TRHR (0.42) | MC4R | |
| SCHEMBL11308630 | 0.85 | ACE (0.45) | MC4RCTSLCTSSCTSKCTSH | |
| SCHEMBL30272525 | 0.83 | F2 (0.56) | MC4RF2CALCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240083943-A1 | VEGF-REGULATING PEPTIDES | IDP DISCOVERY PHARMA, S.L. (ES) | 2024-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240083943-A1 | VEGF-REGULATING PEPTIDES | VEGFA, FLT4, FLT1 | MC4R 237/4885F2 3681/4885CTSL 3263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.